TET2 and neoplasm: TET2-knockout mice have increased IL-6 levels in the seeded tumor tissue, which in turn stimulates the recruitment of immunosuppressive granulocyte myeloid-derived suppressor cells (G-MDSCs) and reduces the number of CD8 T cells during antitumor therapy.